tirzepatide removed from fda shortage list Trade association opposes decision to remove weight-loss drugs Lilly's weight-loss drug removed from

Some of these compoundsparticularly berberine and fiberhave legitimate metabolic effects supported by research

Brain Health and Neurological Benefits Exciting research shows that GLP-1 medications may have impressive effects on brain health: They reduce the risk of Alzheimers disease and dementia They help protect against Parkinsons disease They lower the risk of seizures They may reduce stroke risk and improve recovery after stroke They show benefits for Huntingtons disease in early studies A January 2025 study from Washington University found that people taking GLP-1 medications had a decreased risk of neurocognitive disorders like Alzheimers

Harin M, Jungmi Y

Bei Verstopfung hilft hufig eine Kombination aus ausreichender Flssigkeitszufuhr, langsam gesteigerter Ballaststoffzufuhr und Bewegung

Ultimately, such insights could pave the way for precision nutrition strategies aimed at preventing or managing barrier-related disorders such as inflammatory bowel disease and support early-life or aging gut health where intestinal barrier integrity is especially vulnerable

Rapid weight loss and nutritional stress are well-known triggers for a condition called telogen effluvium , a temporary shedding phase where more hairs than usual shift into the resting (telogen) stage and fall out Recent data suggest that people losing more than about 1520% of their body weight in a relatively short time are especially likely to report shedding, regardless of whether they used GLP-1s or more traditional diet methods In other words, for many people the issue is less Does Ozempic directly cause hair loss? and more Is the speed and style of weight loss putting my hair under stress? What the latest research says about GLP-1 Ozempic hair loss Emerging research has started to look specifically at GLP-1 medications and hair shedding: A large real-world cohort study found a higher incidence of non-scarring hair loss (including telogen effluvium) in people using GLP-1 receptor agonists compared with some other diabetes therapies, though it couldnt prove direct causation